Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.95
0.00 (0.00%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 86 employees as of December 31, 2025. The number of employees increased by 16 or 22.86% compared to the previous year.
Employees
86
Change (1Y)
16
Growth (1Y)
22.86%
Revenue / Employee
$371,814
Profits / Employee
-$692,698
Market Cap
357.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 16 | 22.86% |
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 158 |
| Enanta Pharmaceuticals | 120 |
| Ocugen | 116 |
| Artiva Biotherapeutics | 115 |
| C4 Therapeutics | 104 |
| Surrozen | 44 |
| Fennec Pharmaceuticals | 35 |
| Inhibikase Therapeutics | 35 |
OBIO News
- 10 days ago - Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026 - GlobeNewsWire
- 11 days ago - Orchestra BioMed receives $6.1M milestone payment from Haemonetics - TheFly
- 11 days ago - Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 11 days ago - Orchestra BioMed price target raised to $11 from $10 at B. Riley - TheFly
- 16 days ago - Orchestra BioMed Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 17 days ago - Orchestra BioMed upgraded to Buy from Neutral at BTIG - TheFly
- 24 days ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire